Biotech Values

[amylinterry]

Shakeup or Buyout at AMLN ( Amylin Pharma)

There are 4 entities that have gobbled up all AMLN shares for a voting majority and this does not include Playmakers Goldman Sachs (#5) and Carl Icahn (#6)

Icahn has been pushing down the SP and swallowing every share the last 2 weeks.He also has had "discussions with management " which yesterday yielded the resignation of the longtime head of R&D - Dr A Baron.

Amylin has a great pipline is undervalued and owned by just a few players so the Icahn story is great fodder for speculation. but SP is increasing is one of the things that WILL happen in the not too distant future. A buyout of course first comes to mind. Lilly would love the Diabetes franchaise and everyone wants the Obesity franchaise.
The new 600 M manufacturing plant is absolutely huge and is
producing LAR.

Icahn will not stand for the flattening sales seen for Byetta BID when LAR (long acting Byetta comes to market( 1-2 years depending). Many think Lilly itself is the cause of stalling sales protecting its Insulin franchaise till LAR,but Icahn is making plans now.

Go ahead try and Buy some : ))